Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: Mycoplasma pneumoniae respiratory infections are transmitted by aerosol and droplets in close contact. Aim: We investigated global M. pneumoniae incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March 2020. Methods: We surveyed M. pneumoniae detections from laboratories and surveillance systems (national or regional) across the world from 1 April 2020 to 31 March 2021 and compared them with cases from corresponding months between 2017 and 2020. Macrolide-resistant M. pneumoniae (MRMp) data were collected from 1 April 2017 to 31 March 2021. Results: Thirty-seven sites from 21 countries in Europe, Asia, America and Oceania submitted valid datasets (631,104 tests). Among the 30,617 M. pneumoniae detections, 62.39% were based on direct test methods (predominantly PCR), 34.24% on a combination of PCR and serology (no distinction between methods) and 3.37% on serology alone (only IgM considered). In all countries, M. pneumoniae incidence by direct test methods declined significantly after implementation of NPIs with a mean of 1.69% (SD ± 3.30) compared with 8.61% (SD ± 10.62) in previous years (p < 0.01). Detection rates decreased with direct but not with indirect test methods (serology) (–93.51% vs + 18.08%; p < 0.01). Direct detections remained low worldwide throughout April 2020 to March 2021 despite widely differing lockdown or school closure periods. Seven sites (Europe, Asia and America) reported MRMp detections in one of 22 investigated cases in April 2020 to March 2021 and 176 of 762 (23.10%) in previous years (p = 0.04). Conclusions: This comprehensive collection of M. pneumoniae detections worldwide shows correlation between COVID-19 NPIs and significantly reduced detection numbers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mycoplasma pneumoniae and Its Role as a Human Pathogen
Waites, K. B., & Talkington, D. F. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.697-728.2004 · Cited by 1,339
Cowling, B. J., Ali, S. T., Ng, T. W. Y., Tsang, T. K., Li, J. C. M., Fong, M. W., Liao, Q., Kwan, M. Y., Lee, S. L., Chiu, S. S., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30090-6 · Cited by 1,258 · cited 1×
“Introduction Non-pharmaceutical interventions (NPIs) were suggested to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the worldwide coronavirus disease (COVID-19) pandemic [1].”
BackgroundBrueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C. J., van der Linden, M. P. G., Amin-Chowdhury, Z., Bennett, D. E., Borrow, R., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00077-7 · Cited by 546 · cited 2×
“Reduced transmission by shielding of adults (regardless of school closures) was also discussed as possible reason for the decrease in invasive pneumococcal disease [38].”
BackgroundReporting Guidelines for Survey Research: An Analysis of Published Guidance and Reporting Practices
Bennett, C., Khangura, S., Brehaut, J. C., Graham, I. D., Moher, D., Potter, B. K., & M. Grimshaw, J. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001069 · Cited by 397 · cited 1×
“Survey development A structured survey was developed by a group of members from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), according to guidelines for survey research [21,22].”
Method
Cited by
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
Meyer Sauteur, P. M., Beeton, M. L., Pereyre, S., Bébéar, C., Gardette, M., Hénin, N., Wagner, N., Fischer, A., Vitale, A., Lemaire, B., et al. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00344-0 · Cited by 278
Self-citation
Metadata
- Authors
- Meyer Sauteur, P. M., Beeton, M. L., Uldum, S. A., Bossuyt, N., Vermeulen, M., Loens, K., Pereyre, S., Bébéar, C., Keše, D., Day, J., Afshar, B., Chalker, V. J., Greub, G., Nir-Paz, R., Dumke, R., & ESGMAC–MyCOVID Study Team
- Venue
- Eurosurveillance
- Published
- 2022-05-12
- Volume
- 27
- Issue
- 19
- ISSN
- 1025-496X (ISSN-L)
- 1560-7917
- OpenAlex
- W4280497858
- Cited by
- 162
- References
- 4
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. https://app.cochat.ai/papers/10.2807/1560-7917.es.2022.27.19.2100746
- The paper
- Meyer Sauteur, P. M., Beeton, M. L., Uldum, S. A., Bossuyt, N., Vermeulen, M., Loens, K., Pereyre, S., Bébéar, C., Keše, D., Day, J., Afshar, B., Chalker, V. J., Greub, G., Nir-Paz, R., Dumke, R., & ESGMAC–MyCOVID Study Team. (2022). Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Eurosurveillance. https://doi.org/10.2807/1560-7917.es.2022.27.19.2100746
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.